(Q44088438)

29 November 2017

title

The effects of losartan and fosinopril in hypertensive type 2 diabetic patients (English)

1 reference

29 November 2017

1 reference

Halil Kavgaci

1

1 reference

29 November 2017

Akif Sahin

2

1 reference

29 November 2017

H Onder Ersoz

3

1 reference

29 November 2017

Cihangir Erem

4

1 reference

29 November 2017

Feyyaz Ozdemir

5

1 reference

29 November 2017

language of work or name

1 reference

1 October 2002

1 reference

Diabetes Research and Clinical Practice

29 November 2017

published in

1 reference

29 November 2017

volume

58

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

19-25

1 reference

Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900102-X

7 January 2021

Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney F

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900102-X

7 January 2021

Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900102-X

7 January 2021

Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900102-X

7 January 2021

Nonpeptide angiotensin II receptor antagonists. Studies with EXP9270 and DuP 753.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900102-X

7 January 2021

Renal circulation and blockade of the renin-angiotensin system. Is angiotensin-converting enzyme inhibition the last word?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900102-X

7 January 2021

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900102-X

7 January 2021

Short and long term effects of antihypertensive therapy in the diabetic rat

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900102-X

7 January 2021

Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900102-X

7 January 2021

Contribution of nitric oxide to the beneficial effects of enalapril in the fructose-induced hyperinsulinemic rat

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900102-X

7 January 2021

Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900102-X

7 January 2021

Predicting diabetic nephropathy in insulin-dependent patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900102-X

7 January 2021

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900102-X

7 January 2021

The effect of losartan and captopril on glomerular basement membrane anionic charge in a diabetic rat model.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900102-X

7 January 2021

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900102-X

7 January 2021

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900102-X

7 January 2021

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900102-X

7 January 2021

10.1016/S0168-8227(02)00102-X

Identifiers

DOI

1 reference

29 November 2017

1 reference